FDA integrity contract terminated
Executive Summary
FDA Oct. 4 "Talk Paper" notes that agency has terminated contract with D.C. law firm Shaw, Pittman, Potts & Trowbridge, which had been hired to review integrity of FDA's product review systems. FDA's decision to end the contract follows criticism of the arrangement by Rep. Dingell (D-Mich.) at a Sept. 12 hearing of his House Oversight/Investigations Subcommittee ("The Pink Sheet" Sept. 16, p. 9). Dingell's concern stemmed from comments made by a partner at Shaw, Pittman in an issue of Legal Times that implied the firm would use its experience at FDA to gain new business opportunities. "FDA believes that the need to counter these charges would make fulfillment of the contract more difficult, and the agency made the decision to terminate it at this time," FDA said. The contract for $ 710,558 was signed on July 10 and the firm's report was due on Jan. 9. FDA is not going to hire a replacement. . . .
|
FDA Oct. 4 "Talk Paper" notes that agency has terminated contract
with D.C. law firm Shaw, Pittman, Potts & Trowbridge, which had
been hired to review integrity of FDA's product review systems.
FDA's decision to end the contract follows criticism of the
arrangement by Rep. Dingell (D-Mich.) at a Sept. 12 hearing of his
House Oversight/Investigations Subcommittee ("The Pink Sheet" Sept.
16, p. 9). Dingell's concern stemmed from comments made by a
partner at Shaw, Pittman in an issue of Legal Times that implied
the firm would use its experience at FDA to gain new business
opportunities. "FDA believes that the need to counter these charges
would make fulfillment of the contract more difficult, and the
agency made the decision to terminate it at this time," FDA said.
The contract for $ 710,558 was signed on July 10 and the firm's
report was due on Jan. 9. FDA is not going to hire a replacement. .
. . |